Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Crossed Above 20 DMA | Bullish | -3.68% | |
Pocket Pivot | Bullish Swing Setup | -3.68% | |
Bollinger Band Squeeze | Range Contraction | -3.68% | |
Multiple of Ten Bullish | Other | -3.68% | |
Fell Below 20 DMA | Bearish | -2.12% | |
Bollinger Band Squeeze | Range Contraction | -2.12% | |
Multiple of Ten Bearish | Other | -2.12% |
Alert | Time |
---|---|
Possible NR7 | about 15 hours ago |
10 DMA Resistance | about 18 hours ago |
20 DMA Support | about 18 hours ago |
Down 3% | about 19 hours ago |
Fell Below Previous Day's Low | about 19 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/01/2024
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 53.92 |
52 Week Low | 18.0 |
Average Volume | 1,243,244 |
200-Day Moving Average | 31.74 |
50-Day Moving Average | 46.15 |
20-Day Moving Average | 49.97 |
10-Day Moving Average | 50.40 |
Average True Range | 2.75 |
RSI (14) | 49.49 |
ADX | 29.54 |
+DI | 20.37 |
-DI | 17.73 |
Chandelier Exit (Long, 3 ATRs) | 45.68 |
Chandelier Exit (Short, 3 ATRs) | 53.84 |
Upper Bollinger Bands | 52.58 |
Lower Bollinger Band | 47.36 |
Percent B (%b) | 0.2 |
BandWidth | 10.44 |
MACD Line | 1.08 |
MACD Signal Line | 1.58 |
MACD Histogram | -0.4998 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 51.81 | ||||
Resistance 3 (R3) | 52.17 | 51.40 | 51.25 | ||
Resistance 2 (R2) | 51.40 | 50.54 | 51.22 | 51.06 | |
Resistance 1 (R1) | 49.92 | 50.01 | 49.53 | 49.56 | 50.87 |
Pivot Point | 49.15 | 49.15 | 48.95 | 48.97 | 49.15 |
Support 1 (S1) | 47.66 | 48.28 | 47.28 | 47.30 | 45.99 |
Support 2 (S2) | 46.89 | 47.75 | 46.71 | 45.80 | |
Support 3 (S3) | 45.41 | 46.89 | 45.61 | ||
Support 4 (S4) | 45.05 |